- Firm launches first Zerenia™ medical hashish clinic outdoors of Colombia , exporting confirmed clinic mannequin through strategic partnership with Lima -based Clinica Montesur
- Clinica Montesur is a specialised medical clinic with over 90 medical doctors masking 19 specialties and 11,000 affected person transactions yearly; its clinic is centrally situated in Lima, Peru , a metropolis of 10 million folks or a 3rd of the nation’s whole inhabitants
- Partnership combines Khiron’s distinctive medical hashish experience, together with the Firm’s real-world proof, medical training, greatest practices and methods, with Clinica Montesur’s affected person base, scientific infrastructure and medical workers
- In Q1 2021, Khiron’s medical hashish gross sales in Peru elevated by over 175% in comparison with whole gross sales in 2020
- Zerenia™ is the class chief in medical hashish gross sales in Colombia , with over 20,000 crammed prescriptions and over 8,000 particular person sufferers so far, 50% affected person retention, and common 90% gross margins
- The brand new Zerenia location brings Khiron’s whole clinic rely to 11 throughout Latin America
Khiron Life Sciences Corp. (“Khiron” or the “Firm”) (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMZC), a vertically built-in hashish chief with core operations in Latin America and Europe immediately declares the launch of its first Zerenia TM clinic outdoors of Colombia in Lima, Peru . Following the success of the Firm’s clinic technique in Colombia the brand new clinic has been established as a strategic partnership between Khiron and Clinica Montesur, a specialised medical supplier in Lima with over 90 physicians and greater than 11,000 affected person transactions yearly.
Alvaro Torres , CEO and Director feedback, “I’m happy to announce the primary growth of our Zerenia model past Colombia . Realizing that prescription charges at our Zerenia clinics are 14 instances larger than these of our exterior clinic companions, we’re excited to carry a confirmed advertising and marketing, gross sales, and distribution mannequin to a market of over ten million folks. So far, our Zerenia clinics have performed an important function in not solely introducing sufferers to Khiron merchandise, but additionally in creating an distinctive affected person expertise and rising base of returning sufferers. As we proceed to develop our distinctive, service-oriented platform, we’re proud to introduce Zerenia to the Peruvian market, the place preliminary reception to our merchandise has been sturdy since gross sales started late final 12 months.”
With over 30 years of expertise in Peru , Clinica Montesur is devoted to top quality care throughout 19 areas of specialization, together with oncology, dermatology, ophthalmology, and psychology. As a part of the strategic partnership, Clinica Montesur will present clinic infrastructure, together with its medical facility, clinic permits, methods, and medical workers, amongst others. The partnership will leverage Khiron’s distinctive Zerenia TM medical hashish mannequin, together with the Firm’s medical hashish training platform, real-world proof, and normal working procedures. Sufferers of the clinic will be capable of fill prescriptions for Excessive THC and Low THC (CBD) medical hashish at ten Farmacia Common S.A.C. places all through Lima , as beforehand introduced by the Firm.
About Khiron Life Sciences Corp.
Khiron is a number one vertically built-in medical hashish firm with core operations in Latin America and Europe . Leveraging wholly-owned medical well being centres and proprietary telemedicine platforms, Khiron combines a patient-oriented method, doctor teaching programs, scientific experience, product innovation, and agricultural infrastructure to drive prescriptions and model loyalty with sufferers worldwide. The Firm has a gross sales presence in Colombia , Peru , Germany and the UK, and is positioned to begin gross sales in Mexico and Brazil in 2021. The Firm is led by Co-founder and Chief Govt Officer, Alvaro Torres , along with an skilled and various govt group and Board of Administrators.
Go to Khiron on-line at investors.khiron.ca and on Instagram @khironlife.
This press launch could comprise sure “forward-looking data” and “forward-looking statements” throughout the which means of relevant securities laws. All data contained herein that’s not historic in nature could represent forward-looking data. Khiron undertakes no obligation to touch upon analyses, expectations or statements made by third-parties in respect of Khiron, its securities, or monetary or working outcomes (as relevant). Though Khiron believes that the expectations mirrored in forward-looking statements on this press launch are affordable, such forward-looking assertion has been primarily based on expectations, elements and assumptions regarding future occasions which can show to be inaccurate and are topic to quite a few dangers and uncertainties, sure of that are past Khiron’s management, together with the chance elements mentioned in Khiron’s Annual Data Kind which is obtainable on Khiron’s SEDAR profile at www.sedar.com . The forward-looking data contained on this press launch is expressly certified by this cautionary assertion and is made as of the date hereof. Khiron disclaims any intention and has no obligation or accountability, besides as required by legislation, to replace or revise any forward-looking data, whether or not on account of new data, future occasions or in any other case.
Neither the TSXV nor its Regulation Providers Supplier (as that time period is outlined within the insurance policies of the TSXV) accepts accountability for the adequacy or accuracy of this press launch.
SOURCE Khiron Life Sciences Corp.
View unique content material to obtain multimedia: http://www.newswire.ca/en/releases/archive/June2021/10/c1216.html